The surgeon’s estimation of fibrosis-sclerotic alteration in the thyroid. Part 1
https://doi.org/10.17238/2072-3180-2025-2-192-199
Abstract
Introduction. Intraoperative macroscopic assessment of thyroid diseases is difficult. Fibrosclerotic alterations in the thyroid gland may be found in its benign diseases as well as in malignant neoplasms. The non-specificity of these alterations creates difficulties for the final decision on the extent of surgery.
The purpose of the study. To evaluate the clinical significance of fibrosclerotic alterations in the thyroid gland based on literature data.
Materials and methods of research. Search for literature data in the E-library database using the keywords “fibrosis”, “sclerosis”, “calcification”, “hyalinosis”, “thyroid gland".
Treatment results. Increase of the thyroid stromal connective tissue is a frequent reason for macroscopically seen structural changes and hormonal shifts. The fibrosis and hyalinosis in benign thyroid diseases is a factor for hypothyroidism. The fibrosis, hyalinosis, sclerosis and calcification are the signs of an irreversible transformation with a high probability of tumor and probably is a risk factor of its aggressiveness. Nevertheless, fibrosclerotic alterations in the thyroid gland is not an obligatory sign of a malignant process. Moreover, on morphological examination the process often turns out to be benign. However, the presence of fibrosclerotic alterations is an additional factor for making a decision about the increase of the extent of surgery.
Conclusion. Modern diagnostic methods make it possible to diagnose thyroid disease morphologically with a high degree of accuracy before surgery. However, in the presence of local or widespread thyroid fibrosis, the surgeon must decide a question about the extent of surgery intraoperatively. The intraoperative ultrasound examination can facilitate this task.
About the Authors
V. I. Semikov
Federal State Autonomous Educational Institution of Higher Education Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
Russian Federation
Semikov Vasily Ivanovich – Professor of the Department of Faculty Surgery №2 named after G.I. Lukomski, MD, Professor.
Trubetskaya str., 8–2, Moscow, 119047
Y. K. Aleksandrov
Federal State Budgetary Educational Institution of Higher Education Yaroslavl State Medical University
Russian Federation
Russian Federation
Aleksandrov Yuri Konstantinovich – Professor of the Department of Surgical Diseases with a course in endocrine Surgery named after N.P. Pamputis, MD, Professor.
Revolutsionnaya str., 5, Yaroslavl, 150000
A. M. Shulutko
Federal State Autonomous Educational Institution of Higher Education Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
Russian Federation
Shulutko Alexandr Mikhailovich – Professor of the Department of Faculty Surgery № 2 named after G.I. Lukomski, MD, Professor.
Trubetskaya str., 8–2, Moscow, 119047
J. A. Boblak
Federal State Autonomous Educational Institution of Higher Education Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
Russian Federation
Boblak Julia Alexandrovna – Assistant of the Department of Faculty Surgery No. 2 named after G.I. Lukomsky.
119047, Moscow, st. Trubetskaya 8–2
References
1. Botasheva V.S., Kaloeva A.A., Erkenova L.D. Assessment of proliferative activity of thyroid cells in nodular goiter. Fundamental Research, 2015, № 1(4), рр. 699–703. (In Russ.)
2. Zhang X., Wang X., Hu H., Qu H., Xu Y., Li Q. Prevalence and Trends of Thyroid Disease Among Adults, 1999-2018. Endocr Pract, 2023, № 29 (11), pp. 875–880. https://doi.org/10.1016/j.eprac.2023.08.006
3. Reshetov I.V., Romanchishen A.F., Vabalaite K.V., Kulbakin D.E., Nikiforovich P.A., Rajabova Z.A. Consensus on the treatment of patients with differentiated thyroid cancer T1N0M0. Head and Neck, 2023, № 11 (3), pp. 85–98. (In Russ.) https://doi.org/10.25792
4. Makarov I.V., Galkin R.A., Romanov R.M. Optimization of tactics of surgical treatment of patients with toxic forms of goiter. Medical Almanac, 2024, № 3 (80), pp. 108–114. (In Russ.)
5. Xu C., Jiang R., Liu J.Y. Emerging trends and hot spots in subacute thyroiditis research from 2001 to 2022: A bibliometric analysis. Front Endocrinol (Lausanne), 2023, № 14, рр. 1144465. https://doi.org/10.3389/fendo.2023.1144465
6. Epp R., Malcolm J., Jolin-Dahel K., Clermont M., Keely E. Postpartum thyroiditis. BMJ, 2021, № 372(495). https://doi.org/10.1136/bmj.n495
7. Abstract on the monograph by Pinsky S.B., Dvornichenko V.V., Beloborodov V.A. Thyroid gland tumors. Baikal Medical Journal, 1999, № 18(3), pp. 97. (In Russ.)
8. Araújo A.N., Matos T., Boavida J., Bugalho MJGM. Thyroid tuberculosis: an unexpected diagnosis. BMJ Case Rep, 2021, № 14 (2). https://doi.org/10.1136/bcr-2020-238795
9. Okuma H., Hashimoto K., Wang X., Ohkiba N., Murooka N., Akizuki N., Inazawa T., Ogawa Y. Systemic Sarcoidosis with Thyroid Involvement. Intern Med, 2017, № 56 (16), рр. 2181–2186. https://doi.org/10.2169/internalmedicine.8324-16
10. Polyzos S.A., Anastasilakis A.D. Clinical complications following thyroid fine-needle biopsy: a systematic review. Clin Endocrinol, 2009, № 71(2), рр. 157–65. https://doi.org/10.1111/j.1365-2265.2009.03522.x
11. Friedman M.V. Fibrosis in differential morphologic diagnostics of papillary thyroid cancer. Medical Journal, 2006, № 1 (15), pp. 116–118. (In Russ.)
12. Khmelnitsky O.K. Histologic diagnostics of non-tumor thyroid diseases: Manual for doctors. Edited by Prof. G.B. Kovalsky. St. Petersburg, 1999, 56 pp. (In Russ.)
13. Chen J., Ye D., Lv S., Li X., Ye F., Huang Y., Su Z., Lin Y., Xie T., Wen X. Benign thyroid nodules classified as ACR TI-RADS 4 or 5: Imaging and histological features. Eur J Radiol, 2024, № 175(111261). https://doi.org/10.1016/j.ejrad.2023.111261
14. Sencha A.N., Timofeeva L.A., Tukhbatullin M.G., Nasrullaev M.N., Alekseev S.S. Modern ultrasound imaging technologies in the diagnosis of papillary thyroid cancer. Acta Medica Eurasica, 2022, № 4, pp. 58–64. (In Russ.)
15. Toniato A., Brusoni M., Mirabella M., Pomba L., Mourmouras V., Scapinello A., Battistella E. Papillary thyroid carcinoma with fibromatosis-like stroma: a case report and review of the literature. BMC Endocr Disord, 2023, № 23(1), рр. 80. https://doi.org/10.1186/s12902-023-01337-y
16. Suster D., Michal M., Nishino M., Piana S., Bongiovanni M., Blatnik O. Papillary thyroid carcinoma with prominent myofibroblastic stromal component: clinicopathologic, immunohistochemical and next-generation sequencing study of seven cases. Mod Pathol, 2020, № 33, рр. 1702–1711. https://doi.org/10.1038/s41379-020-0539-7
17. Harach H.R., Franssila K.O., Wasenius V.M. Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer, 1985, № 56(3), рр. 531–538.
18. Roukain A., la Rosa S., Bongiovanni M., Lalonde M.N., Cristina V., Montemurro M. Papillary thyroid carcinoma with desmoid-type fibromatosis: review of published cases. Cancers, 2021, № 13, рр. 4482. https://doi.org/10.3390/cancers13174482
19. Koperek O., Scheuba C., Puri C., Birner P., Haslinger C., Rettig W. Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma. Int J Oncol, 2007, № 31(1), рр. 59–67.
20. De Wever O., Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol, 2003, № 200 (4), рр. 429 – 447.
21. Argunov V.A. Histological characterization of papillary thyroid cancer. Siberian Oncologic Journal, 2006, № 3, pp. 84–85. (In Russ.)
22. Ji Y.L., Shin J.H., Han B.K., Eun Y.K., Seok S.K., Ji Y.K. Diffuse sclerosing variant of papillary carcinoma of the thyroid: Imaging and cytologic findings. Thyroid, 2007, № 17, рр. 567–573. https://doi.org/10.1089/thy.2006.0321
23. Houas J., Ghammam M., Chouchane L. An unusual presentation of diffuse sclerosing variant of papillary thyroid carcinoma. Egypt. J. Otolaryngol, 2022, № 38 (78). https://doi.org/10.1186/s43163-022-00269-z
24. Koperek O., Scheuba C., Cherenko M., Neuhold N., De Micco C., Schmid K.W., Niederle B., Kaserer K. Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential. Histopathology, 2008, № 52 (5), рр. 623–630. https://doi.org/10.1111/j.1365-2559.2008.03002.x
25. Olifirova O.S. Autoimmune Hashimoto’s thyroiditis in surgical practice. Far Eastern Medical Journal, 2021, № 3. (In Russ.) URL: https://cyberleninka.ru/article/n/autoimmunnyy-tireoidit-hashimoto-v-hirurgicheskoy-praktike (date of address: 09.03.2025)
26. Goodman H.I. Riedel’s thyroiditis: a review and report of two cases. American journal of surgery, 1941, № 2, рр. 472–478.
27. Pandev R., Khan M., Ratheesh V. Riedel’s Thyroiditis: Pitfalls in Diagnosis and Subsequent Complications. Case Rep Endocrinol, 2023, № 9989953. https://doi.org/10.1155/2023/9989953
28. Pokrovskaya E.V., Beltsevich D.G., Abrosimov A.Y., Lischuk S.V., Voskoboynikov V.V., Chevé A. Riedel’s thyroiditis. An observation from practice. Endocrine Surgery, 2019, № 13 (3), pp. 133–140. (In Russ.) https://doi.org/10.14341/serg10324.
29. Özge Ö., Göknur Y., Bartu B., Emel T. A rare case of Riedel’s thyroiditis: Immunoglobulin G4-related thyroid disease. JCEM Case Reports, 2023, № 1 (1) https://doi.org/10.1210/jcemcr/luac014.055
30. Davydovich M.G., Ipaeva R.V., Derevyanko H.P. Difficulties of diagnostics and choice of treatment of Riedel’s fibrosing thyroiditis on the example of clinical cases. Creative Surgery and Oncology, 2022, № 12 (1), pp. 74–80. (In Russ.) https://doi.org/10.24060/2076-3093-2022-12-1-74-80
31. Falhammar H., Juhlin C.C., Barner C. Riedel’s thyroiditis: clinical presentation, treatment and outcomes. Endocrine, 2018, № 60 (1), рр. 185–192. https://doi.org/10.1007/S12020-018-1526-3
32. Vahidy A.S., Tebha S.S., Chavarria Y., Kc S., Sharma S. Clinical presentation and organ-based outcomes of Multifocal fibrosclerosis: A systematic review. SAGE Open Med, 2023, № 11, рр. 20503121231178046. https://doi.org/10.1177/20503121231178046
33. Lanzillotta M., Culver E., Sharma A., Zen Y., Zhang W., Stone J.H., Della-Torre E. Fibrotic phenotype of IgG4-related disease. Lancet Rheumatol, 2024, № 6 (7), рр. 469–480. https://doi.org/10.1016/S2665-9913(23)00299-0
34. Strukov A.I., Serov V.V. Pathologic anatomy. 6 ed., supplement. Moscow: “GEOTarmedia”, 2015, рр. 90–91. (In Russ.)
35. Aleksandrov Y.K., Yanovskaya E.A., Baranov G.A. Rare pathology of the thyroid gland: unspecified thyroiditis. Fibrinoid swelling. Modern Problems of Science and Education, 2024, № 2. (In Russ.) URL: https://science-education.ru/article/view?id=33360 (date of address: 19.04.2024).
36. Liu Y.J., Ge F.M. Multiple myeloma characterized by synovial fibrinoid necrosis: a case report. J Int Med Res, 2021, № 49 (1), рр. 300060520982844. https://doi.org/10.1177/0300060520982844
Review
For citations:
Semikov V.I., Aleksandrov Y.K., Shulutko A.M., Boblak J.A. The surgeon’s estimation of fibrosis-sclerotic alteration in the thyroid. Part 1. Moscow Surgical Journal. 2025;(2):192-199. (In Russ.) https://doi.org/10.17238/2072-3180-2025-2-192-199
Views:
81
Email this article 